Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation, which typically diminish with gradual dose titration
One vial typically covers several months of reconstitutions depending on your vial sizes
As with compounded semaglutide, the general active ingredient category is similar, but the regulatory status is different
Many steroids convert to estrogen through the aromatase enzyme, producing water retention, potential gynecomastia, and a softer appearance that contradicts recomposition goals
Dysesthesia This covers abnormal sensations that do not fit neatly into pain or sensitivity categories
Retatrutide is an investigational triple hormone receptor agonist with no regulatory approval